Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells
- 1 May 1993
- journal article
- Published by Elsevier in Kidney International
- Vol. 43 (5), 1010-1014
- https://doi.org/10.1038/ki.1993.142
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritisAmerican Journal Of Medicine, 1990
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Recombinant Human Erythropoietin for Patients with AIDS Treated with ZidovudineNew England Journal of Medicine, 1990
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- Epoetin (Recombinant Human Erythropoietin)Drugs, 1989
- Correction of Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin: Safety and Efficacy of One Year's Treatment in a European Multicentre Study of 150 Haemodialysis-Dependent Patients*Nephrology Dialysis Transplantation, 1989
- Rheology in Whole Blood and in Red Blood Cells under Recombinant Human Erythropoietin TherapyPublished by S. Karger AG ,1988
- Clinical Effect of Recombinant Human Erythropoietin on Anemia Associated with Chronic Renal Failure. A Multiinstitutional Study in JapanThe International Journal of Artificial Organs, 1988
- Blood Rheology and Hypertension in Hemodialysis Patients Treated with ErythropoietinAmerican Journal of Nephrology, 1988
- Blood Pressure Changes during Treatment with Recombinant Human ErythropoietinPublished by S. Karger AG ,1987